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Abstract
Measles is an infectious disease caused by the Morbilivirus Measles
Virus which has accompanied the human race since the 4th millennium
BC, it is a disease usually concerning the paediatric population and in the
past, before the advent of vaccination, almost all the population suffered
from it, and in some cases the complications derived from this disease,
such as central nervous involvement. Vaccination changed the course of
the disease worldwide and diminished the associated comorbidities and
mortality; in Mexico the vaccination program commenced in the decade
of the 1970s and was successful in preventing peaks of infection. Nev-
ertheless, due to various factors, has the world seen measles outbreaks
once more, this commencing in the year 2019 and extending towards the
year 2020. Here we make account of the biology and the pathophysiol-
ogy of the viral infection, and present three models: one concerning the
dynamics of the cases by means of a continuous method and a discrete
stochastic model; one concerning the cellular compartmentalization be-
haviour of the virus, that is the viral tropism towards certain cell types
in the host and the tendencies in extended or complicated infection; the
last one concerning geographic behaviour of the virus, regarding in par-
ticular the tendencies in Mexico City, those involved at a global scale, and
finally a model providing a prediction of the viral genotypes’ distribution
worldwide.
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1 Introduction
Measles is an infectious viral disease with a Paramyxoviridae member as the aetiologic
factor, the measles virus, a negative-sense single-stranded RNA virus, and it may pro-
duce dermatologic lesions as well as respiratory signs had there been no preventive
measures taken, for it was by means of the introduction of the massive immunization
programs that the incidence rate of this infection were reduced dramatically, never-
theless it has been seen that immunization is sometimes avoided because of misinfor-
mation or other causes, due to this fact, the rate of measles has once more risen. This
virus may be transmitted by means of aerosols or in fomites in a lesser extent. It has
been postulated that measles originated from modern canine distemper or rinderpest
viruses in the Epipaleolithic Age (10 000 BC), and that it became a human disease in
Mesopotamia in the 4th millennium BC (Retief & Cilliers, 2010).
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2 Biology and pathophysiology of measles virus
Measles virus (Measles morbillivirus) is a member of the genus of viruses Morbilivirus
which belongs to the subfamily Orthoparamyxovirineae, belonging itself to the fam-
ily Paramyxoviridae; these viruses being negative sense RNA viruses (Wang, et al.,
2018). The RNA genome of this virus is approximately 16 kbp containing six genes
encoding six structural proteins: nucleocapsid (N), phosphoprotein (P), matrix (M),
fusion (F), haemagglutinin (H) (the haemagglutinin protein and the fusion protein
later form a heterooligomer in order to promote membrane fusion (Hashiguchi, Mae-
naka, & Yanagi, 2011)) and large (L) proteins; along with two non-structural proteins:
V protein and C protein (Rota, et al., 2016). It has been seen that the viral particles
vary in diameter from 50 to 510 nm in its wild-type form (Liljeeros, Huiskonen, Ora,
Susi, & Butcher, 2011). Strains of these virus have been characterized in regards to the
genetic variability of the H and the N proteins, 8 clades and 24 genotypes: A, B1-B3,
C1-C2, D1-D11, E, F, G1-G3, H1-H2), as it was witnessed in the 2013 to 2016 measles
outbreak in Cameroon, in which B3 strains featured the panorama (B3.1, B3.2, B3.3,
U64582 MVi/Johannesburg.ZAF/0.88/1[D2] (Obam Mekanda, et al., 2019). Three
receptor proteins have been noted in hosts for measles virus: SLAM, CD46 and nectin
4 (Hashiguchi, Maenaka, & Yanagi, 2011).
2.1 MV proteins
2.1.1 Haemagglutinin
This protein is a type II membrane glycoprotein displaying four domains: N-terminal
cytoplasmic tail, transmembrane region, a stalk, C-terminal receptor-binding head
domain; the latter exhibits a six-bladed beta-propeller fold, which is found in other
paramyxoviruses and human proteins (Hashiguchi, Maenaka, & Yanagi, 2011), the
beta-propeller fold is a highly symmetrical fold with paired repeats of a four-stranded
antiparallel beta-sheet motif, in the interaction between the sheets is provided the
hydrophobic character of the propeller augmenting the structure’s stability (Pons,
Go´mez, Chinea, & Valencia, 2003). Since the H protein lacks the neuraminidase
domain, it targets SLAM, CD46 and nectin-4. This protein contains a top pocket which
resembles the sialic acid binding cavity present both in haemagglutinin-neuraminidase
and neuraminidase proteins, but this H protein lacks sialic acid-binding activity. The
head domain homodimerizes (Hashiguchi, Maenaka, & Yanagi, 2011), this head has
been seen to further dimerize, forming then a dimer of dimers and postulations in
regards to the role of the tetramer formation in promoting membrane fusion have been
made (Nakashima, Shirogane, Hashiguchi, & Yanagi, 2013). The glycosylation in this
protein occurs between amino acids 168 and 238 (as seen in Edmonston type virus) but
wild type viruses possess an additional glycosylation site at amino acid 416 these sites
are glycosylated in an N manner. The fusion activity is triggered by the H binding to
receptors, promoting conformational changes in F protein (Lin & Richardson, 2016);
another function of the H protein is to mediate virus adsorption onto the cellular
membrane of the host (Saitoh, et al., 2012). Genetic variability in the H gene has been
noted and appears to have a geographic pattern, with the genotypes D4 and D6 mainly
found in European countries, while D3, D5, D9 and H1 in Asian countries (Saitoh, et
al., 2012). This protein exhibits antigenicity and humoral immunity is directed mainly
towards the H protein, being its epitopes: hemagglutinating and noose epitope (HNE),
receptor-binding epitope (RBE), sugar-shielded epitope (SSE), neutralizing epitope
3
(NE), and loop epitope (LE). The HNE is formed by amino acids from 379 to 400 and
three cysteines from the noose motif forming a disulphide-constrained surface-exposed
loop, this epitope is well conserved among measles virus strains. The RBE is found at
the lateral side of the propeller fold, a Phe552 interacts with SLAM, and a mutation in
this site induces immune escape; the epitope recognized by the monoclonal antibody
BH26 (MAb-BH26) in the RBE is said to be the most important immunodominant
epitope, MAb-BH26 inhibits the binding of 60% of human serum antibodies in measles
patients or vaccines. A glycosylated amino acid at the 416 position shields a specific
epitope from monoclonal antibody recognition (E128 and BH99), said sugar was gained
in an ancestral strain (since G3, H1 B2, B3, D6 genotypes lack a glycosylated motif
in this amino acid site) (Tahara, et al., 2016). Genetic evolution of the H protein
has been witnessed, being the oldest strain: A (1948); and the most recent divergent
ones: H1 and H2 (1978 and 1986, respectively); with an estimated evolution rate of
9.02x10−4 substitutions/site/year (Kimura, et al., 2015).
2.1.2 Fusion protein.
This protein is involved in the viral membrane fusion with that one of the host, by
means of an initial conformational change induced by the H protein, decreasing the
distance between the membranes and by the protein’s structural change can both
membranes fuse; this process is not only important for the viral entry into the cell but
as well to promote cell-to-cell spread forming syncytia (or multinucleated cells) such
as the Warthin-Finkeldey cell (or reticuloendothelial giant cell) in lymphoid tissue,
epithelial giant cell in epithelium, but it has been also noted that the endothelium
may as well be induced to form syncytia (Takeuchi, Miyajima, Nagata, Takeda, &
Tashiro, 2003). The F protein is a type I integral transmembrane and class I viral
fusion protein which homotrimerizes, each F monomer is initially synthesizes as a long
precursor F0, then by means of the Golgi network, this precursor is cleaved into F1
and F2, then linked by means of two disulphide-bonds from F1 to F2 subunits, this
process is mediated by furin (Plattet, Alves, Herren, & Aguilar, 2016) this protein is
another type I transmembrane protein which exhibits homology with other proprotein
convertases, belonging to the subtilisin superfamily of serine endoproteases, this pro-
tein shows conserved residues in the catalytic triad, this protein is pH-dependent with
a range from 5 to 8, this dependent on the substrate to be cleaved (Thomas, 2002)
it may be inhibited by decanoic acid and pirfenidone (TyersLab, 2020). Trimeriza-
tion of the F protein occurs at the endoplasmic reticulum, in the same place where
H as well oligomerizes, promoting the formation of membrane fusion machineries and
F-H heterooligomers, however this interaction’s affinity diminishes once F0 is cleaved.
There are well-conserved regions: cytoplasmic and transmembrane domains, two hep-
tad repeat regions (HRA, HRB, HRC), N-terminal hydrophobic segment. Since this
protein is a class I viral fusion protein, it is initially folded in an intrinsically high en-
ergy structure (prefusion state) maintained by means of a high energy barrier carrying
then on spontaneous (from a low entropy state) changes in its structure unto a stable
low energy, high entropy state (postfusion state) with a central core six-helix bundle
domain. The F protein (in other paramyxoviruses) unveils a short stalk region with
three HRB regions supporting a globular domain, this latter globular domain with
three subdomains (DI, DII, and DIII), this DIII domain suffers drastic changes when
transiting from pre- towards postfusion states while DI and DII suffer less dramatic
conformation movements. The conformational changes induced in the F protein, by
means of the anchoring of the transmembrane domain in the viral envelope and the
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closure of the fusion peptide with the host membrane, ensure changes in the membrane
curvature and an exergonic membrane fusion with the concomitant pore formation.
Several F protein inhibitors have been proposed, such as peptides, antibodies and
small molecule; in this small molecule class, we have: AS48 with a molecular mass of
299.09Da, and a polar surface area of 1.18nm2 (Royal Society of Chemistry, 2020)),
JNJ-2408068 with a molecular mass of 394.248108Da, and a polar surface of 0.92nm2
(Royal Society of Chemistry, 2020)), JNJ-49153390 with a molecular mass of 504.4Da
and a polar surface area of 0.97nm2 (Royal Society of Chemistry, 2020)), TMC-353121
, BTA9881, BMS-433771 (Plattet, Alves, Herren, & Aguilar, 2016).
2.1.3 Phosphoprotein.
This protein attaches to the ribonucleoprotein complex of measles virus (that is, RNA
bound to the nucleocapsid protein); it is as well a cofactor for the L protein. This
phosphoprotein (P) has two domains: an N-terminal domain (playing a role in viral
replication) and a C-terminal domain (involved in both replication and transcrip-
tion). The N-terminal domain associates with the newly synthesized nucleoprotein
N0 functioning as its chaperone. Fully functional N provides two interactions with
the N-terminal domain of the P protein, say the N core domain with the N-terminal
domain and the N tail domain with the C-terminal domain interact, mediating the
binding of the P protein to the newly synthesized N protein, this prevents the bind-
ing of the N protein with host RNA. The XD region of the P protein induces proper
folding of the N tail domain. The P protein interferes with the JAK1/STAT path-
way, degrading STAT1 or preventing the phosphorylation of JAK1 or STAT1; JAK1
and STAT1 both of them activate IFNA, IFNB, IFNG and IL10, as well as several
members of the gp130 family of proteins (IL6, IL11, CNTF, CT1, GCSF, LIF, OSM)
(Rawlings, Rosler, & Harrison, 2004); due to this fact could we approach the lack
of immune response towards the virus by means of JAK/STAT signalling pathway
activators or to directly administrate substrates of the downstream signalling path-
way; moreover, STAT1 has shown to promote epigenetic changes by means of the
H3C1 histone, therefore, could Measles virus be able to change the epigenetic land-
scape of the host (Rui, et al., 2016). This XD region has been modelled to possess
53 amino acid residues, 64 water molecules, and (in the crystallization method) one
molecule of 2-n-(cyclohexylamino)ethanesulfonic acid (Johansson, et al., 2003), due
to this binding could we look into a similar molecule which could show promise in
P protein inhibition such as 4-methyl-5-(beta-hydroxyethyl)thiazole monophosphate
which shows thiamine-phosphate diphosphorylase activity (PubChem, 2020). The P
protein may also display anti-apoptotic features (for it has been seen that an increase
in both BCL2 and BCLXL associates with an increase of the P protein concentration;
as well as an increase in vimentin expression by means of the P protein (Bhattacharjee,
Kumar Jaiswal, & Kumar Yadava, 2019).
2.1.4 Nucleoprotein.
This N protein is composed of two regions, one spanning the amino acids from 1 to 391,
the N core region; and another one spanning the amino acids from 392 to 525, the N
tail region; the N core region is an ordered one, while the N tail region is an intrinsically
disordered one (these intrinsically disordered regions of domains are found in nearly
all species and function to allow the same protein to interact with different substrates
and thus, to be part of different signalling networks (Wright & Dyson, 2015)). The
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N core region contains two domains (NTD and CTD) which are flanked by N- and
C-terminal arms; N oligomerization is mediated by means of exchange of the NT arm
and the CT arm; the RNA binding site is on the groove between two N core domains.
This protein composed as well by a tetramerization domain, MD, forming: four-helix
coiled-coil, C-terminal domain (extreme), XD, disordered regions; the L protein (RNA
polymerase) complexes with P and then attaches to NC by means of the XD domain in
P and the molecular recognition element. P plays an important role in N metabolism,
for it acts as a chaperone to keep the newly synthesized N protein in an RNA-free
monomeric form, as well as it positions the polymerase complex for polymerization
(Guryanov, Liljeeros, Kasaragod, Kajander, & Butcher, 2016). The association of N
core with RNA forms helices, each helix is composed of 12.34 nucleoprotein subunits
per turn, with a slope of 4.9 nm and an outer diameter of 19 nm; the RNA winds
around the N protein in a bobbin-like fashion (Gutsche, et al., 2015), this binding of
the RNA to the N protein arises from the phosphates and 2’ oxygen of the ribose, but
not interactions dependent on sequences, in regards to the kinetics of this binding, each
N protein protomer binds to 6 RNA bases (Guseva, Milles, Blackledge, & Ruigrok,
2019).
2.1.5 V protein.
This protein is encoded by the P gene along with two other proteins (say R and C),
containing a unique Cys-rich C-terminus; C, V and R are identical for the first 231
amino acids, afterwards there exists a divergence induced by various mechanisms. The
cysteines at the C-terminus may mediate zinc binding (these type of proteins (zinc-
binding proteins) require zinc to become stable and the concentrations required of
zinc for such stability is [50, 100]µM (Terada & Yokoyama, 2015)), being able then to
contain zinc-finger-like domains (the first zinc-finger protein was found to be able to
DNA by means of the cysteine repeats within the sequence, with some of these pro-
teins displaying transcriptional or ubiquitin activity (Cassandri, et al., 2017)). Two
functions of this protein have been widely recognized: induce changes in the STAT
pathway (Parks, et al., 2006) this blockage has been seen to be by means of interaction
with STAT1, STAT2, IRF9 and STAT3, blocking of STAT2 phosphorylation and pre-
venting activation of JAK1 (Pfaller & Conzelmann, 2008), interfering with interferon
synthesis and inhibiting viral RNA synthesis, it has also been noted to be able to bind
to RNA possibly by means of the zinc-finger-like structure it possesses; the role of
this protein in RNA synthesis inhibition is possibly to maintain a correspondence of
viral protein concentration in the cytoplasm to RNA synthesis or to maintain a ratio
of genome to antigenome (Parks, et al., 2006). The V protein has shown high affinity
to both IKKA and IRF7, it also competes with IRF7 in phosphorylation; preventing
interferon induction and promoting to the immunosuppressive seen in measles patients
(Pfaller & Conzelmann, 2008).
2.1.6 L protein.
This protein has properties of nucleotide polymerization, 5’ capping, and polyadeny-
lation (Ito, et al., 2013) in this case the polyadenylation serves as a gene end signal,
proceeding over three nucleotides without transcribing them and restarting the tran-
scription when recognizing the gene start signal (Bloyet, et al., 2016). As we have
previously commented the V protein inhibits RNA synthesis but also the C protein
does it so (which also derives from the P gene) (Parks, et al., 2006); the replication ma-
6
chinery of measles virus is comprised by the N, P and L proteins (Bloyet, et al., 2016).
The L protein derives from a 6644 nucleotide gene, translated into a 2183 amino acid
protein (with a molecular weight of around 250 kDa) with two highly variable regions
(hinges): H1 (from amino acid 607 to 650) and H2 (from amino acid 1695 to 1717)
which may form protein boundaries. In this protein there lay six conserved sequences,
being H1 a region of low homology. Furthermore, it has been seen that by tagging H1
with fractions of MYC may compromise the whole L protein polymerization function,
nevertheless this occurs not when the tag was added to the H2 region; posing the idea
that the highly variable region is a quite important factor for proper protein function,
this possibly by means of a reorientation of the critical catalytical domain (D2), do-
main which itself shows a high degree of conservation (78.9%) (Paul Duprex, Collins,
& Kima, 2002). The L protein might interact with SHCBP1 as not enough information
was available to confirm or deny such interaction, the latter protein being inhibited by
the C protein in order to decrease interferon response (Ito, et al., 2013), SHCBP1 is a
protein linked to cell proliferation by means of regulation of cell cycle progression and
apoptosis due to SHCBP1 interacting with CDK4-cyclin D1 cascade, and suppression
of caspase-3, and caspase-dependent apoptotic pathways (Dong, Yuan, Yu, Tian, & Li,
2019); promoting then an invasive phenotype; thus through the C protein (and likely,
the L protein) inhibition of SHCBP1 is measles virus available to promote further cell
death or cell cycle progression arrest in invaded cells.
2.2 Host proteins.
2.2.1 SLAM.
These SLAM (signalling lymphocytic activation molecule) receptors are a family of cell
surface type I transmembrane glycoprotein receptors on exception of SLAMF2 (with
a glycosylphosphatidylinositol membrane anchor) (Detre, Keszei, Romero, Tsokos,
& Terhorst, 2010), also a subfamily of the CD2-like family of proteins (Yurchenko,
et al., 2018). These proteins contain an N-terminal V-Ig domain and a C-terminal
C2-Ig domain, nevertheless, SLAMF3 is made up only by two V-Ig/C2-Ig domains.
This family of proteins is comprised by 9 different receptors, these proteins are their
own ligands and bind in a homophilic manner, with SLAMF1 as the only member of
the family of proteins which is known to interact with measles virus (Detre, Keszei,
Romero, Tsokos, & Terhorst, 2010). SLAMF1’s gene is found at the chromosomal
location 1q23.3 and exhibits 8 exons, it has been seen to be expressed in the following
tissues: lymph node, spleen, appendix, bone marrow, colon, duodenum, gall blad-
der, stomach, urinary bladder and others; this protein is associated with treatment
refractory schizophrenia and to susceptibility in inflammatory bowel disease (NIH,
2020). This family of proteins’ importance is seen when the phenotype of SHD21A
-/- is witnessed, provided the fact that SH2D1A regulates SLAM members signalling,
inducing X-linked lymphoproliferative disease , in which there is an innate immune
response deficiency towards EBV (Huang, et al., 2016), promoting fatal mononucle-
osis, fatal haemophagocytic lymphohistiocytosis (due to EBV, lymphomas, antibody
deficiency, other causes of immune dysregulation) (Filipovich, Zhang, Snow, & Marsh,
2010). SLAMF1 may mediate signalling via the TNF family and antigen receptors and
regulate innate immune responses, as it is seen in SLAMF1 -/- bone marrow-derived
macrophages which produce less ROS in Escherichia coli response, since SLAMF1
promotes NOX2 activity by complexing with beclin-1, PIK3C3 (VPS34), VPS15, and
UVRAG; and that by means of its interaction with TLR4 it induces TRAM-TRIF-
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dependent signalling (Yurchenko, et al., 2018). In T cells, SLAMF1 is expressed
on immature CD4(-) CD8(-) thymocytes but high titres of expression are shown in
CD4(+) CD8(+) thymocytes, and not present at the surface of monocytes, but seen on
their activated form (monocytes/macrophages lineages), nevertheless, in non-activated
monocytes, SLAMF1 is seen expressed in their cytoplasm in the recycling compart-
ments (this subcellular region is localized near the microtubule-organizing centre at the
perinuclear region (Xie, et al., 2015)); also seen expressed in mature dendritic cells;
neutrophils, eosinophils and erythrocytes are SLAMF1(-); in B cells, the SLAMF1
expression is seen promoted in the stage towards plasma cells differentiation; also
seen in human-induced pluripotent stem cells; in regards to malignancies, it has been
seen expressed in malignant T cells in cutaneous T-cell lymphoma and Se`zary syn-
drome (Gordiienko, Shlapatska, Kovalevska, & Sidorenko, 2019). In a cellular model
of chronic lymphocytic leukaemia, a deficiency in SLAMF1 would induce increased
expression of CXCR4, CD38 and CD44, affecting chemotaxis by CXCL12; SLAMF1
also appears to have a role in autophagy due to the induction of phosphorylation of
p38, JNK1/2, and BCL2 (promoting autophagy) and SLAMF1-deficient cells appear
to display resistance to autophagy-inducer drugs (Bologna, et al., 2016); it is likely
that by means of this mechanism there is a display in lymphoma regression in mice
(Chung, 2001). SLAMF1 binds to H in a 1 : 1 ratio with a kd = 0.52 ± 0.21 µM
and exhibits a 10.5nm2 contact area with four components of the binding interface:
salt bridges of Asp505 and Asp507 to the acidic patch in H at Lys77 and Arg90;
Arg553 at H to Asp350 at H and Glu123 at SLAMF1 and two hydrophobic interac-
tions of H Phe55s and Pro554 with His61 and Val63 at SLAMF1; beta-sheet between
Pro191-Arg195 at H and Ser127-Phe131 at SLAMF1; the 4th site is hydrophobic; this
interaction diminishes the distance between the host and viral membranes to around
14nm, followed by a conformation change in F which allows F to interact with the
target cell membrane and ending with membrane fusion (Hashiguchi, et al., 2011).
2.2.2 CD46.
The gene encoding for this protein is found at chromosomal location 1q32.2 with 14
exons; this protein is a type I transmembrane protein and part of the complement
system by inactivating C3b and C4b, thereby protecting the cell from damage by
the complement system; it also acts as one of the receptors for measles virus, hu-
man herpesvirus-6 (NIH, 2020), some adenoviruses, Streptococcus pyogenes, Neisseria
gonorrhoeae (Yamamoto, Fara, Dasgupta, & Kemper, 2013), Neisseria meningitidis,
Escherichia coli, Fusobacterium nucleatum (Liszewski & Atkinson, 2015); it is as well
associated with the fusion of spermatozoa with oocytes and CD46’s gene mutations
are associated with susceptibility to haemolytic uremic syndrome (NIH, 2020). The
location of this gene is in the gene cluster named ‘regulators of complement activity’
on chromosome 1 (Yamamoto, Fara, Dasgupta, & Kemper, 2013), said cluster spans
21.45 cM of this chromosome with more than 60 genes which share an ancestral mo-
tif; they are composed of a repeating unit, the complement control protein module
(comprising a sushi domain) however CD46 lacks the DAA fragment, through which
other complement-related proteins enhance the spontaneous decay of the convertases
(Liszewski & Atkinson, 2015). This protein is expressed in four isoforms from alter-
native splicing mechanisms, and the four of these isoforms show C3b and C4b binding
sites, following this complement-proteins binding domains we find a glycosylated re-
gion (in which alternative splicing may occur), then a region of unknown function,
a transmembrane anchor, and two cytoplasmic domains: CYT1 and CYT2. The re-
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sulting isoforms of this protein are: C1, BC1, C2, BC2. When deficiencies in the
CD46 gene exist, an overactivation of the complement system may occur, promot-
ing C3b deposition on host endothelium and systemic microthrombi formation (such
as atypical haemolytic uremic syndrome and age-related macular degeneration) (Ya-
mamoto, Fara, Dasgupta, & Kemper, 2013); genetic variations of CD46 have been
associated with various inflammatory disorders and not only with the haemolytic ure-
mic syndrome but furthermore with systemic sclerosis, earlier development of nephritis,
HELLP syndrome, recurrent miscarriage, C3 glomerulonephritis, common variable im-
munodeficiency, preeclampsia, systemic lupus erythematosus (Liszewski & Atkinson,
2015). The binding of measles virus to CD46 may not only promote the fusion with the
membrane of the host but as well to facilitate the breach of immune barriers of the host
or (and) to create a favourable immune microenvironment. In epithelial cells, CD46
is phosphorylated by YES1 (homolog of the Yamaguchi sarcoma virus oncogene) ty-
rosine kinase member of the Src family and may promote cytoskeletal rearrangements
that favour infection by some pathogens by its interactions with ezrin; when CD46
interacts with DLG4 (membrane-associated guanylate cyclase (MAGUK)) the actin
cytoskeleton suffers changes and the epithelial cell loses its polarity, the changes in
the cytoskeleton are driven by autophagosomes; CD46 when interacting with DLG4
may also come into play with SCRIB (scribble planar cell polarity protein) playing
then a role in mitotic spindle formation and epithelial tumour formation. In mono-
cytes it has been seen that upon CD46 activation by the H protein, there exists a
down-regulation of IL12 (Yamamoto, Fara, Dasgupta, & Kemper, 2013) which dis-
plays structural similarities to the IL6 family (as well as with IL31 and IL23) and uses
a gp130 ortholog to transduce its signal by means of the JAK/STAT pathway, and in
IL12 case, uses JAK2 and STAT1, STAT3, STAT4, and STAT5 proteins in the trans-
duction of its signal, IL12 production is intrinsically bound to dendritic cells’ ability
to recognize pathogens and promote Th1 responses, as well as to mediate resistance to
intracellular infections, for instance, IL12 -/- mice were seen to be more susceptible to
pathogens such as: Leishmania, Plasmodium, Toxoplasma, Cryptococcus, Francisella
and Mycobacteria (Tait Wojno, Hunter, & Stumhofer, 2019). The affinity of CD46
with the H protein was computed to be kd = 0.2 µM , the r.m.s. corresponding to
the superposition of the dimer has been noted to be equal to 0.133 nm while the
interacting surface areas equal in average 10.775 nm2 (Santiago, Celma, Stehle, &
Casasnovas, 2009).
2.2.3 Nectin-4
The gene encoding this protein is found at the chromosomal location 1q23.3 with 9
exons within the genetic structure, member of the nectin family, from this we remem-
ber that the cell-adhesion molecules belong mostly to 4 classes of molecules: integrins,
selectins, immunoglobulin superfamily, and cadherins; the nectin family of proteins
is found within the immunoglobulin superfamily, this family is featured by a single-
pass type-I membrane glycoproteins; in nectin-4 and other splice variants, the afadin-
binding motif is not conserved, being this motif the one responsible for binding with
the PDZ domain of afadin (afadin is a protein involved in signalling and organization
of cell junctions (NIH, 2020)). It has been seen that nectin-4 displays heterophilic
interactions with nectin-1 and homophilic interactions with itself, this plays a role in
cell-cell adhesion where one nectin molecule protrudes from one cell and encounters
another nectin molecule protruding from a different cell, associating thereof. Of special
remark, nectin-4 is not the only member of the nectin family which shows affinity for
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viral proteins, for both nectin-1 and nectin-2 have exhibited interaction with proteins
of herpes simplex viruses (HSV1 and HSV2) (Samanta & Almo, 2015). Within the pro-
tein we may find two Ig-like C2-type domains and one Ig-like V-type domain; involved
in cell adhesion being a single-pass type I membrane protein. It possesses a soluble
form through proteolytic cleavage by means of the metalloproteinase ADAM17/TACE.
Associations have been made of this gene’s base pair substitutions with ectodermal
dysplasia-syndactyly syndrome type 1 (NIH, 2020). Furthermore, nectin-4 has been
used as a tumour marker and has been positively correlated with both cell prolifera-
tion and angiogenesis, with an increase in nectin-4 expression meaning a concomitant
increase in VEGF expression (Nishiwada, et al., 2015). Nectin-4 has been seen to ef-
fectively bind to an anti-nectin-4 antibody, say enfortumab vedotin, which may show
potential in diminishing measles virus infectivity by inducing conformational changes
in nectin-4 and thereof, decreasing the amount of possible receptors to use in the host
(Challita-Eid, et al., 2016).
2.3 Insights into pathophysiology.
After viral entry into host cells, the viral RNA is sensed intracellularly by DDX58 and
MDA5 (Rota, et al., 2016) where DDX58 is a DExD/H-box helicase, a DEAD box pro-
tein, the ones have RNA helicases, implicated in RNA binding and alterations of RNA
secondary structure; DDX58 contains a caspase recruitment domain (CARD), involved
in the recognition of viral double stranded RNA (NIH, 2020); DDX58 has exhibited
TLR4-dependent activation by means of LPS, therefore playing a role in phagocy-
tosis, for it has been seen that DDX58 depletion leads to macrophage phagocytosis
deficiencies (Kong, et al., 2009), this TLR4-stimulated DDX58 pathway furthermore
promotes TNFA expression; DDX58 also induces IFN type I expression by means of
a TLR3-independent pathway, and by means of its CARD and the ATP-dependent
catalytic centre domains of DDX58 which activate IRF3, NFKB and IFNB (Wang,
et al., 2008) this NFKB and IRF3 activation is possible by means of DDX58 interac-
tion with mitochondrial protein MAVS (Zeng, et al., 2010), a mitochondrial antiviral
signalling protein which regulates expression of beta interferon and contributes to an-
tiviral immunity (NIH, 2020), MAVS regulates the recruitment of molecules involved
in mitochondria-associated complexes: the adaptors TRAF3, TANK and TRADD; the
kinases TBK1, IKKE; which in turn promote the transcription of IRF3 and IRF7 with
a subsequent synthesis of IFN type I; whereas NFKB augments the production of IL1B
and IL6. DDX58 has shown to activate inflammasomes in a similar manner in which
double-stranded DNA does so with AIM2 inflammasomes (with double-stranded DNA
viruses), for when DDX58 associates with ASC induces caspase 1 activation (Poeck,
et al., 2010), therefore being part of the NLRP1B inflammasome and promoting py-
roptosis and IL1B expression by means of proteolytic cleavage of both gasdermin D
and Pro-IL1B (Broz & Dixit, 2016). MDA5 or IFIH1 (interferon induced with heli-
case C domain 1) is a DEAD box protein with a putative RNA helicase, involved in
RNA secondary structure changes, it is upregulated in response to IFNB and mez-
erein (PKC-activating compound) (NIH, 2020) also interacts with MAVS in a similar
manner in which DDX58 does and induces NLRP1B inflammasome activation with
a promotion in caspase 1 activation and finally both pyroptosis and IL1B expression
(Dias Junior, Sampaio, & Rehwinkel, 2018). It has been seen that Laboratory of Ge-
netics and Physiology 2 (LGP2) is able to respond to viral DNA when the measles
virus vaccine is administered (by means of recognition of 5’ copy-back defective in-
terfering genomes) (Mura, et al., 2017). Measles evades immune response by means
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of its V, C and P proteins; where the V protein binds to MDA5 and LGP2, inhibit-
ing IFN synthesis (Rota, et al., 2016); LGP2 is a DExH-box helicase 58 (NIH, 2020)
but in distinction of both MDA5 and DDX58, LGP2 lacks a CARD domain; LGP2
regulates the activity of both MDA5 and DDX58 in response to viral RNA; LGP2
shows a greater affinity for double-stranded RNA than DDX58 and may prevent the
latter protein from binding to viral RNA and could even inhibit DDX58 function; this
regulation of functions of DEAD box proteins is mediated by LGP2 and its partners,
some of which are well-known, such as: DICER1, PKR, NKRF, STAU1, DHX30,
XRN2; some others have been recently noted: MOV10, SRRT, RBM4 and PACT;
these partners and the master regulator LGP2 could promote RNA silencing as an
antiviral response, promote MDA5 function, diminish DDX58 activity and thus could
play a role in decreasing pyroptosis of infected cells by means of NLRP1B inflamma-
some formation inhibition (Sanchez David, et al., 2019). Moreover, has it been seen
that LGP2 increases beta-catenin levels and decreases GSK3B expression (Zhou, et
al., 2019) which would phenotypically promote cell proliferation (Gopalkrishna Pai,
et al., 2017); therefore should LGP2 be inhibited by means of measles virus’ proteins,
there would be a dysregulation of DDX58 functioning (promoting NLRP1B inflam-
masome and pyroptotic death) and a decrease in cell viability due to an increase in
GSK3B and decrease in beta-catenin expression; corresponding with the lymphopoe-
nia seen in patients with measles infection, with decreased numbers of: CD4(+) T
cells, CD8(+) T cells, B cells, neutrophils, monocytes (Okada, et al., 1999) due to
this fact does there exist a tendency towards opportunistic infections such as those
seen with other CD4(+) T cell deficiency: human herpes viruses (Orren, et al., 1981),
CMV, mycobacteria, toxoplasma, salmonella (Ul Haq Lodhi, Imam, Umer, & Zafar,
2017), pneumocystis (seen in patients with concomitant HIV and measles infection
(Rafat, et al., 2013)), candida, among others. A myeloid suppression has also been
seen, and may be a reason for which adolescents and adults tend to show more compli-
cations derived from measles infections than children or newborns, due to the rate of
proliferation and differentiation from bone marrow (Manchester, Smith, Eto, Perkin,
& Torbett, 2002). In an interesting fashion, individuals with a susceptible genetic
background and environmental features could promote the induction of a cytokine
storm (Tisoncik, et al., 2012) should they suffer from a measles infection, by means of
a lack of control of NLRP1B inflammasome, IL1B and TNFA production, inhibition
of LGP2 and others, in whom we may observe hypotension (Hahne´, et al., 2016) and
pulmonary fibrosis (Montella, Santamaria, Maglione, & Ciofi degli Atti, 2009). As
we have previously discussed, the tropism of the virus is determined by the affinity
of the H protein towards three host receptors, say CD46, nectin-4 and SLAMF1; the
expression of either of these in the cellular surface could promote inhibition of cellular
proliferation and promotions in apoptotic pathways, the cellular tropism or compart-
mentalization of the virus is further discussed in the ‘Models’ section in which we may
realize the long-term clinical consequences of these tropism.
3 Clinical features.
Infection by MV has been seen to begin with an incubation period in which the virus
replicates within myeloid and lymphoid cells, thus establishing a systemic infection
(Rota, et al., 2016). Measles is an acute febrile disease. Symptomatically it begins at
the prodromal phase of the infection, lasting from 2 to 4 days, in which fever (greater
than or equal to 311.8 K), cough, coryza, conjunctivitis are seen, in a rather similar
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way to a higher airways infection. In the 2 to 4 days following the onset of the fever
the rash appears, an erythematous maculopapular exanthema, starting at the head
and neck to continue towards the thorax and limbs. During the following 3 to 5 days,
the rash in different parts of the body wanes in the order in which it appeared, and
the full recovery starts within the next seven days in non-complicated cases (Moss,
2017) (Strebel & Orenstein, 2019). Koplik stains, small white to blueish white plaques,
appear at the oral mucosa and are seen in 70% of the cases, they may appear from 1
to 2 days before the rash, and may be from 1 to 2 days after the rash has disappeared,
they are considered pathognomonic (Rota, et al., 2016) (Strebel & Orenstein, 2019).
Photophobia and mild gastrointestinal symptoms have also been considered part of
the disease (Drutz, 2016). Many typical clinical signs in measles infection may also be
caused by other infectious diseases, including: rubella, parvovirus B19, herpes virus
type 6 and dengue (Rota, et al., 2016). Measles-associated complications may be due
to factors related to the host’s immune response, favouring then secondary bacterial
infections; complications such as diarrhoea (8 %), pneumonia (1 to 6%) and otitis
media (7 to 9%) are seen. Central nervous involvement is also seen and complications
such as post-infectious encephalitis (1 in every 1000 cases) and subacute sclerosing
panencephalitis (1 in every 1000 cases) may occur (Rota, et al., 2016) (Strebel &
Orenstein, 2019). The complication risk augments with age, and an association has
been seen in regards to higher susceptibility to complications in children with low
vitamin A intake, as well as those who suffer forms of immunosuppression (Strebel
& Orenstein, 2019). Motherly-acquired IgG antibodies protect the newborn from
measles; in general, these antibodies last in the newborn around 9 months. Measles
is an infection related to newborns and children who live in urban environments with
low vaccination coverage. Measles cases tend to predominate in scholar children (5
to 10 years of age). This average age may switch to teenagers or even adults if the
vaccination coverage diminishes even more, which requires then an effort to promote
immunization in older age groups (Rota, et al., 2016).
4 Preventive measures: vaccination.
The high transmissibility of measles virus may be explained in terms of the high
viral charges in the upper airways during the prodromal and early rash phases, in
combination with the epithelial damage inducing a cough reflex. This combination
turns into measles virus-aerosol generation, promoting respiratory transmission (Rota,
et al., 2016). The best preventive measure against measles is vaccination; all measles
vaccines contain live attenuated strains of measles virus; most of the strains derive
from the Edmonston prototype strain (say, Moraten, Schwartz and Edmonston-Zagreb
strains), although other wild-type-derived vaccines such as CAM-70 and Leningrad-16
exist (Moss, 2017). Measles vaccine may be administered as a combined vaccine against
rubella and mumps; the application of the combined vaccine against rubella-measles
provides the opportunity to diminish both rubella and congenital rubella syndrome
incidence (Moss, 2017). Various studies regarding the effectiveness of the measles
vaccine have encountered a high effectiveness after a dosage administered at 12 months
of age or later has been performed (average effectiveness, 93%), and even a higher
effectiveness after two dosages have been administered (median effectiveness, 97%).
The WHO advises on a two-dosage schema of the measles immunization as a standard
prophylaxis in measles prevention (Strebel & Orenstein, 2019). The WHO advises on
the first dosage of the vaccine to be at 9 moths of age. The ratio of children who
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develop a suitable measles antibody response is approximately 85% at 9 months of
age and 95% at 12 months of age. The necessary amount of populational immunity in
order to prevent measles transmission is not accomplished by means of a single dosage
of the vaccine; for a second dosage should be administered. The campaigns aim for
the second dosage to be administered at an age range from 5 to 15 years (Moss, 2017).
The immunity induced by the vaccine most likely lasts in most of those who have been
vaccinated. The MMR vaccine poses an acceptable range of secondary effects; these
events include fever (< 15% of the receptors), transient cutaneous rash (7 to 12 days
after the vaccine administration in a 5% of the receptors), transient lymphadenopathy
(5% in children and 20% in adults), parotitis (< 1%) and aseptic meningitis (1 to 10
in a million) (Strebel & Orenstein, 2019).
5 Models.
5.1 SIR model
5.1.1 Stochastic approach.
Let us consider a compartmental model of disease, in which we have five blocks or
states: susceptible, vaccinated, infected, recovered, dead:
S
−→
k1 V
↓ ↙
I
−→
k2 R
↓ k4
D
These compartments may be interpreted as states in a discrete Markov chain, with
the set of states then being, H = {S, V, I, R,D} with a bijective function towards
the set S = {si, i ∈ N} such that f : H → S, we have already noted that every
“reaction” (with an analogy towards chemical reactions) displays a constant ki, and a
set of parameters, in which this set is T = {ti ∈ N}, the stochastic matrix P for this
chain is the following,
Variables S V I R D
S 0.409365773 0.58593183 0.004702398 0 0
V 0 0.99999995 5.14851x10−8 0 0
I 0 0 0.2727272 0.63438041 0.0928232
R 0 0 0 1 0
D 0 0 0 0 1
Let us set the initial vector to be,
pi0 =

0.4141068143
0.58593179
6.82407× 10−8
0
0

T
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We may approximate the stationary distribution to be,
pi ≈

2.3359× 10−249
0.99667048
7.05563× 10−8
0.00290419
0.00042526

T
Therefore, we may realize that in the long term, the whole population will tend to be
vaccinated, and only a small amount of it will become infected, however an even lesser
amount of the population will still be susceptible, this due to either the effect of im-
munity from a previous infection or because of the vaccination status, this susceptible
status in the long term appears to be even negligible. The mortality is set to be 4 in
every 10,000 members of the population and the recovery rate to be 2 in every 1,000
subjects. Let us now compute the eigenvalues of the stochastic matrix,
Λ =

1
1
0.99999995
0.409365773
0.2723272
 ≈ (Pii)T
That is the eigenvalues approach the transpose of the diagonal of the stochastic matrix;
from this we gather that the greatest eigenvalue is λ1 = λ2 > λ3 > λ4 > λ5; where
the spectral radius r = λ1 = λ2 = 1 is associated with two eigenvectors, say u and v,
u =

1.016911685× 10−3
0
0.1277269272
0
1

In this case, the leader vertex or state is the D state, followed by the I state, let us
continue with the v eigenvector,
v =

6.944695232× 10−3
0
0.8722729765
1
0

Now, the leader vertex is the R state followed by the I state; being the two leader
vertices R and D and the second leader-vertex being in both of the cases the I state.
5.1.2 Non-stochastic approach.
Alternatively, we may consider a non-stochastic approach; let us consider the following
system of equations,
−dS
dt
= −d(S0 − x− y)
dt
=
dx
dt
+
dy
dt
= k1 (S0 − x) + k2 (S0 − y)
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Which describes the formation of both vaccinated and infected populations from the
susceptible set. Now,
−dV
dt
= −d (x− y)
dt
= −dx
dt
+
dy
dt
= k3 (x− y)
Describes the rate of formation of infected people from the vaccinated set. Finally,
−dI
dt
= −d (x+ y − u− z)
dt
=
du
dt
+
dz
dt
− dx
dt
− dy
dt
= k3 (x+ y − u) + k4 (x+ y − z)
And,
−dR
dt
= −du
dt
= 1
−dD
dt
= −dz
dt
= 1
We may group them,
x′ + y′ = S0 (k1 + k2)− k1x− k2y
−x′ + y′ = k3x− k3y
u′ + z′ − x′ − y′ = k3 (x+ y − u) + k4 (x+ y − z)
−u′ = 1
−z′ = 1
For which we may define a matrix Y,
Y =

x
y
u
z
1

of the variables involved in the process and a constant; a matrix A,
A =

−k1 −k2 0 0 S0(k1 + k2)
k3 −k3 0 0 0
k3 + k4 k3 + k4 −k3 −k4 0
0 0 0 0 1
0 0 0 0 1

And a matrix Y ′,
Y ′ =

x′
y′
u′
z′

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Then would we have a system of differential equations,
AY = Y ′
This linear system has a solution (Zill, 2009),
Y (t) =
n∑
i=1
eλitVi
For which we shall define the constants (k1 stands for the rate of the ‘real’ vaccinated
individuals in the susceptible population, this done with the data from the National
Mexican Committee of Vaccination which reported vaccination rates from 1990 to
2000, due to the fact that the second dosage tends to happen at the second year of
age, the data presented is only the one from the dosages administered, independent
of the fact whether it is the first or the second dosage, due to this, we computed the
real vaccination rate from 1995 forth when we know the actual amount of vaccinated
people, who have already received the second dosage; for this constant we have also
considered the fact that geographic areas with less than or equal to 1500 inhabitants
were not taken into account in the vaccination schema, then we subtracted the amount
of those born in rural areas in those periods; therefore we may consider this constant
to be the rate of those who have received the second dosage of the vaccine who lived in
geographic areas of more than 1500 inhabitants. k2 stands for the rate of those infected
from the susceptible pool. k3 stands for the rate of recovered patients from the infected
pool. k4 stands for the rate of mortality from infected patients. k5 stands for the rate of
infected from the vaccinated pool. We have also considered the susceptible population
to be 146.54x106 following the exponential rule of population applied to Mexico, this
is because there is no data available (yet) from the 2020 census),
Constant V alue± SD
k1 0.585931829± 0.07229194
k2 0.004702398± 0.000218881
k3 0.634380406± 0.4407335
k4 0.092892322± 0.176686532
k5 5.14851x10
−8 ± 1.07708x10−7
In the former equation, λi is the i-th eigenvalue of the A matrix and Vi the i-th
eigenvector associated with said eigenvalue; in this case, we obtain the eigenvalues of
the matrix for the values of the matrix ki = ki (no standard deviation involved),
Λ1 =

0
1
−0.634380406
−0.6699049694
−0.5504072656

The eigenvectors for given eigenvalues are shown,
Var-EV v1 v2 v3 v4 v5
x 0 54637446.31 0 -0.0289759648 0.01349724863
y 0 21207379.41 0 -0.1019658193 0.1019658193
u -0.146429987 33749715.19 1 1 1
z 1 1 0 0 0
1 0 1 0 0 0
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Thus, displaying the solution,
Y1 (t) = v1 + e
tv2 + e
−0.634380406tv3 + e
−0.6699049694tv4 + e
−0.5504072656tv5
We show now the eigenvalues for the cases ki ± sd,
ki ± sd ki − sd
-1.086791796 1
-1.07445376 -0.510888052
1 -0.197058898
-0.6458857338 -0.19430706
0 0
The eigenvector for ki − sd,
Var-EV v1 v2 v3 v4 v5
x 50136913.64 -7.416910083 3.577164711x10−4 0 0
y 8156994.64 4.552256859 −0.02525833169 0 0
u 5394111.985 1 1 1 0.4312463479
z 1 0 0 0 1
1 1 0 0 0 0
And the one for ki + sd,
Var-EV v1 v2 v3 v4 v5
x 1.066376173x10−4 0 58693455.2 0.09092105197 0
y −9.286501305x10−3 0 30400004.5 0.2279462307 0
u 1 1 57723395.53 1 -0.2508985124
z 0 0 1 0 1
1 0 0 1 0 0
Such that we obtain the solutions,
Y (t) =
 ki → v1 + etv2 + e−0.634380406tv3 + e−0.6699049694tv4 + e−0.5504072656tv5ki − sd→ etv1 + e−0.510888052tv2 + e−0.197058898tv3 + e−0.19430706tv4 + v5
ki + sd→ e−1.086791796tv1 + e−1.07445376tv2 + etv3 + e−0.6458857338tv4 + v5

5.2 Cellular compartmentalization.
SLAMF1, Nectin-4 and CD46 show specific cellular expression patterns, thereof we
may take advantage of this in order to compute the temporal distribution of viral
tropism in the host. Let us call the existence of expression of either protein a condition
ci and the set of possible cells with the condition ci, V = {l1, l2, . . . , ln}; we postulate
the following,
∀ln ∈ V ∃R|ci ∈ (lj ∧ lk)→ (ljRlk ∧ lkRlj)
Such that two cells possessing the same condition will exhibit a relationship, this
feature builds up to a graph. This graph G is defined by G = (V,E) where V is the
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Figure 1: Graph exhibiting the adjacency matrix of the tisular/cellular expres-
sion of SLAMF1, nectin 4 and CD46.
set of vertices and E is a set of edges; the graph has an adjacency matrix M (Fig. 1)
with the adjacency condition,
mij = (C = {ci}) , |C| ∈ ln → |C|
The ij-th member of the matrix of adjacency shall be equal to the cardinality of
the set of conditions the specific cell expresses. We are going to approximate the eigen-
values of this matrix by means of the Gershgorin circle theorem (Fig. 2) (Weisstein,
2020), thereof we possess a matrix M with mij ∈ C, and for each i, we define the disc,
Di =
z ∈ C : |z −mii| ≤∑
j 6=i
|mij |

That is, the radius of the disc is lesser than the sum of all the non-diagonal entries
of the matrix, and the eigenvalues (the matrix of eigenvalues is defined as Λ) of M lie
in,
Λ ⊂
n⋃
i=1
Di
Should we consider Λ ⊂ R then would we obtain Λ ∈ [−147, 153] that is, that our real
eigenvalues lie in that range (by observation of the adjacency matrix we realize that
max
∑
i,j |mij | = 150 corresponding to the node of prostate, therefore, this may lead
our thought to the possible fact that prostate is the leader vertex of the network and
that the radial spectra r of the network is r = maxλ ≤ 153). When we convert our
adjacency matrix to a stochastic one, we learn then from the stationary distribution
of the corresponding Markov chain that the virus shall tend to remain in: lymph
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Figure 2: Graphic representation of the Gershgorin theorem applied to the
approximation of the eigenvalues corresponding to the adjacency matrix of the
cellular compartmentalization of measles virus interactions in the complex plane.
node, tonsil, appendix, terminal ganglion, retina, amygdala, spinal cord and CD105(+)
endothelium (Fig. 3) which may clinically correlate to advanced stages of disease such
as encephalitis (terminal ganglion) which has been reported to be one of the most
common complications of measles virus infection (Fisher, Defres, & Solomon, 2014),
other not so common complications include retinitis (Neppert, 1994), tonsillitis (Lai,
Lin, Wang, & Chen, 2017) and induction of giant cells observed in appendix promoting
then appendicitis (Whalen, Klos, Kovalcik, & Cross, 1980).
5.3 Geographic distribution tendencies
5.3.1 Analysis of the Mexico City outbreak.
Let us consider Mexico City and its boroughs as elements of a network in which certain
rates of individuals leave one borough and enter another, whereas those from the other
borough leave this one and enter the first one, there exists a ‘reversible’ process however
with obvious different rates; these allows us to build a discrete model of the large-scale
population behaviour in Mexico City. For these rates we will consider data obtained
from the subway system of the city as well from rates of traffic from main avenues.
Due to the fact that the subway system of Mexico City only reports the affluency of
each subway station, we need to know how many people enter to every borough from
another borough or remain in the same borough, therefore let us consider the following
schema,
A ⇀↽ B
Where the rate of A towards B is k1 and the rate of B towards A is k2; in order
to determine how many people stay in a borough or leave it, we will consider that
in regards to the subway movements, the amount of people who come down from a
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Figure 3: Graph showing the − log10 (pi) where pi refers to the i-th probability.
specific set of stations within a borough is proportional to the ratio of the population
of that borough,
ki α r
where r stands for the ratio r = Pb
Pt
where Pb stands for the population of the borough
and Pt for the total amount of population, in this model we consider the populations
of the states of Mexico and Morelos as if they were ‘boroughs’, in order to take in
account the very important interactions Mexico City poses with these states (Fig. 4).
Figure 4: Population ratios of each borough comprising Mexico City and
metropolitan area.
We may imagine this model as a balloon being pinched in the both ends (repre-
senting a borough being pierced by a subway line) with some people already in the
balloon, some entering by means of the initial pierce, and some more leaving towards
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the second pierce, however we ought to account for all of the ‘pinches’ this balloon
endures, therefore, we need to know all the affluency towards this borough, the af-
fluency original of this borough and the effluency from this borough; therefore some
people will stay in the borough and some other will leave, the way in which we shall
know how many people will stay in every borough is by means of the ratio r we have
already commented. Let us provide an example, the Gustavo Adolfo Madero borough
is ‘pierced’ by five subway lines, some originating in these borough, some others do
not, Line B comes from Mexico State, therefore we compute the affluency Am of those
stations from Line B located at Mexico State, then, some people from this affluency
will stay in Mexico State while some others will pierce towards Gustavo Adolfo Madero
(GAM) borough, the amount of those who stay at Mexico State are sm = rm • Am
that is the stay rate equals the ratio of population Mexico State possesses rm times
the affluency from the stations; while those who enter are then e = Am − sm, in here
this entry population mixes with the affluency of those who enter the subway stations
at the GAM borough with an affluency AG, now some people will leave the borough
and some others will stay, the amount of those who shall stay is sG = rG × AG thus
the amount of those who leave is e = AG−sG; this becomes quite easily an algorithm,
in which we compute the affluency from the root borough, those who stay, those who
leave, those who enter into a new borough, and so forth. At the end of the algorithm,
we obtain valuable quantities, those are the total amount of people who are found
at the borough at a given time, let us call this quantity l the entry plus affluency,
l = ei +Ai, this allows us not to count twice a person and to normalize our stochastic
process. Then, we sum the quantities l for each borough, followed by a description
of those lines that pierce from the balloon outwards, these being outflows or rates of
outside flow, if the borough is, for instance, GAM, then line B pierces out towards
Cuauhte´moc, then the ratio of the exit flow and the sum of the l quantities of the
borough GAM will provide us the actual rate of flow φ from one borough to the other,
φ =
ei∑
(li)
This rates of flow for each borough have a feature,
n∑
i=1
φi = 1
Then we realize these rates of flow are indeed transition probabilities, and members
of rows from a random matrix, in this case, rows from a stochastic matrix (Fig. 5)
corresponding to the Markov process of Mexico City inhabitants’ movements by means
of the subway affluencies. The states of this Markov process are the boroughs S = {si}
and the temporal parameter is a discrete one. We are in position now to describe the
Mexico City outbreak, which we will represent by means of the initial vector of the
Markov process pi0 whose probabilities are given by a frequentist view of the cases
in Mexico City, that is, pi =
c
n
the probability of transition pi equals the ratio of
the amount of cases in the i-th borough and the total number of cases n (Fig. 6).
When we compute the distribution of probabilities in different moments, we obtain
a graph which is shown in Fig. 6 in which we may regard that in time, the areas
less affected by measles will tend to be Cuajimalpa (piC = 1.024x10
−194), Magdalena
Contreras (piMC = 5.9876x10
−40), Tlalpan, Xochimilco, Milpa Alta and Morelos with
similar rates; the areas with the higher likelihood to present cases or to concentrate
more cases are A´lvaro Obrego´n with piAO = 0.207358185 and State of Mexico with
piSM = 0.20140335.
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Figure 5: Stochastic matrix of human movements in Mexico City.
Figure 6: Evolution of probabilities distribution of measles cases in different
moments of the temporal parameter.
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5.3.2 Analysis of global outbreak.
We present a Markov chain in which the discrete states are the countries worldwide
S = {si} and the temporal parameter is one for which the dimension remains to be
determined, however the time is discrete; the existence of a probability of transition
pij between one i-th country and a j-th is by means of a physical political boundary
sharing or a connection through a commercial flight, the stochastic matrix is shown in
Fig. 7.
Figure 7: Stochastic matrix displaying the interactions nations have amongst
them in terms of physical interactions (political territory boundaries) and air
trafficking.
The initial vector corresponds to the amount of global cases worldwide, where
pii =
ci
ct
and ci stands for the amount of cases of measles in that i country and
ct stands for the total amount of cases; the quantities of cases were obtained from
the WHO reports from 2019 and the Mexican Health Ministry from 2020, therefore,
our initial vector stands for that temporal unit between January 2019 and March
2020. By computing the stationary distribution, are we able now to predict a long-
term distribution of the cases worldwide, taking in account the various air traffic
influences in the transmissability of measles; this stochastic matrix could be of use
in many other infectious diseases or even modern patterns of migration. When we
compute the probability vectors in different moments in time, we obtain the Fig. 8
in which there exists a high homogenization in the distribution of cases worldwide,
however when we compare the vectors when n = 0 ∧ n = 128 (Fig. 9) we observe
that those countries that started with p=0 of cases, they preserve such probability;
the countries with the highest concentration of cases are those with the highest rate
of interactions with other countries: France (p = 0.02328), Turkey (p = 0.0228462),
South Africa (p = 0.0198728), United Kingdom (p = 0.0198559); being then the
European continent the one with the highest contribution to the cases; Mexico shows
a contribution of 0.723% of the cases worldwide. Those countries with p = 0 are: East
Timor, Eswatini, Kirbiati, Marshall Islands, Federated States of Micronesia, Nauru,
23
Seychelles and Tuvalu.
Figure 8: Probability vectors when n = 32 ∧ n = 128, we can tell of a much
smoother homogenization in the distribution of probabilities.
Figure 9: Distribution of probabilities vectors corresponding to cases worldwide,
comparing n = 0 ∧ n = 128.
5.3.3 Genotype tendencies at the global scale.
As previously discussed, the measles virus shows diversity by means of changes to its
H protein, in which we may note several genotypes of the virus, these genotypes are
time- and space-dependent, and we will describe these genotype fluctuations in a time-
dependent manner in their geographic distribution using the adjacency matrix devised
in the subsection ‘Analysis of global outbreak’ in order to promote preparedness in
countries in regards to the idiosyncrasies of infection of each genotype, and develop-
ment of more directed vaccines or therapies. The adjacency matrix of the countries
will be converted unto a stochastic one, the Markov chain associated to the stochastic
matric shows a set of states S = {si} in which every si state is a country, T is the
temporal parameter and in this case the units are not defined, and the temporal pa-
rameter set is T = {ti ∈ N} such that the time parameter is a discrete one. Every
genotype will display an initial vector and will be an independent Markov process;
these initial vectors are shown in Fig. 10. When the number of iterations n=8, then
do we obtain Fig. 11, where we regard that for those initial pi0i 6= 0, there exist the fol-
lowing distributions, e.g.: Angola shows max(pi8An) = 0.007393 corresponding to B2,
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Austria shows max(pi8Au) = 0.0151245 corresponding to D6, Republic of the Congo
shows a maximum of p = 0.0047079 corresponding to B2, Denmark shows a maximum
of p = 0101149 corresponding to D4; for example, in the case of Mexico, we know from
the information from the Ministry of Health (SALUD, 2020) that the D8 genotype is
the one prevalent in the 2020 measles outbreak, and the max(pi8Mex) = 0.00073567
which corresponds indeed to the D8 genotype, from this we may gather that air traffic
and political limits between countries are indeed determinants in measles virus’ geno-
types spread and distribution worldwide; therefore there exist transitions between one
initial state towards a different one in time; the observation of these changes is a pri-
ori, should we want to know whether migration, air traffic is a determinant of measles
virus’ genotypes, we need to promote a posteriori study in order to correlate each
probability.
Figure 10: Worldwide geographic distribution of measles genotypes, initial
vectors for each genotype.
Figure 11: Geographic distribution of measles virus genotypes when n=8.
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